Citadel Advisors
OXGN

Citadel Advisors’s OXIGENE INC COM OXGN Stock Holding History

Citadel Advisors’s Portfolio OXGN Stock Details OXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-46,163
Closed -$74K – 9379
2014
Q4 		$74K Buy
+46,163
New +$88.8K ﹤0.01% 6919

Other funds holding OXGN

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Citadel Advisors's OXGN Position: Q1 2015 in Review

Citadel Advisors sold out of OXIGENE INC COM (OXGN) in Q1 2015, closing a stake of 46,163 shares — an estimated $74K sold.

Citadel Advisors first reported a position in OXGN in Q4 2014 and held it in 1 quarter. The position peaked at $74K in Q4 2014. 27 funds tracked by Wall St. Rank hold OXGN as of Q1 2015.

  • Citadel Advisors reported no remaining OXIGENE INC COM position as of Q1 2015 after selling out during the quarter.
  • Citadel Advisors sold 46,163 OXIGENE INC COM shares in Q1 2015, an estimated $74K.
  • Citadel Advisors first reported a position in OXIGENE INC COM in Q4 2014 and held it in 1 quarter.
  • Citadel Advisors's OXIGENE INC COM position peaked at $74K in Q4 2014.
  • 27 funds tracked by Wall St. Rank held OXIGENE INC COM as of Q1 2015.

Based on Citadel Advisors's 13F filing for Q1 2015, filed 15 May 2015.